Related references
Note: Only part of the references are listed.Transforming growth factor-β pathway activity in glioblastoma
Karl Frei et al.
ONCOTARGET (2015)
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
Jordi Rodon et al.
INVESTIGATIONAL NEW DRUGS (2015)
The Aryl Hydrocarbon Receptor: Multitasking in the Immune System
Brigitta Stockinger et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma
Hans-Georg Wirsching et al.
BRAIN (2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
Integrin inhibition promotes atypical anoikis in glioma cells
M. Silginer et al.
CELL DEATH & DISEASE (2014)
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
Paula Codo et al.
ONCOTARGET (2014)
TGF-β as a therapeutic target in high grade gliomas - Promises and challenges
Justin V. Joseph et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Integrin control of the transforming growth factor-β pathway in glioblastoma
Patrick Roth et al.
BRAIN (2013)
Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
Stephen Safe et al.
TOXICOLOGICAL SCIENCES (2013)
Semi-quantitative immunohistochemical assay versus oncotype DX® qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance study
James A. Kraus et al.
MODERN PATHOLOGY (2012)
Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors
Simon L. Goodman et al.
BIOLOGY OPEN (2012)
Xenobiotics and Loss of Cell Adhesion Drive Distinct Transcriptional Outcomes by Aryl Hydrocarbon Receptor Signaling
Nan Hao et al.
MOLECULAR PHARMACOLOGY (2012)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth
Cornelia Dietrich et al.
CARCINOGENESIS (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism
Tiffany Kung et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro
Gabriele D. Maurer et al.
NEURO-ONCOLOGY (2009)
Aryl hydrocarbon receptor inhibition downregulates the TGF-β/Smad pathway in human glioblastoma cells
D. Gramatzki et al.
ONCOGENE (2009)
The search for endogenous activators of the aryl hydrocarbon receptor
Linh P. Nguyen et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
AhR- and c-maf-dependent induction of β7-integrin expression in human macrophages in response to environmental polycyclic aromatic hydrocarbons
Patricia Monteiro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible genes in human amniotic epithelial cells
Yumiko Abe et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2006)
Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells
SH Juan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Evidence that ligand binding is a key determinant of Ah receptor-mediated transcriptional activity
IA Murray et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model
S Mulero-Navarro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Similar sequence-free amplification of human glyceraldehyde-3-phosphate dehydrogenase for real time RT-PCR applications
G Carraro et al.
MOLECULAR AND CELLULAR PROBES (2005)
Cell density regulates intracellular localization of aryl hydrocarbon receptor
T Ikuta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Integration of Smad and Forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation
J Seoane et al.
CELL (2004)
Overexpression of latent transforming growth factor-β binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts
B Santiago-Josefat et al.
JOURNAL OF CELL SCIENCE (2004)
Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-β-binding protein-1
J Corchero et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2004)
Disruption of cell-cell contact maximally but transiently activates AhR-mediated transcription in 10T1/2 fibroblasts
YC Cho et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer
DW Nebert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Effects of 2,3,7,8-TCDD and PCB 126 on human thymic epithelial cells in vitro
K Riecke et al.
ARCHIVES OF TOXICOLOGY (2003)
Share Paper
